ER (Estrogen Receptor)
27 drugsPredictive biomarker for patient selection in 16 indications
27
Approved Drugs
16
Indications
23
Companies
ER (Estrogen Receptor) is a precision-medicine biomarker linked to 27 FDA-approved targeted drugs from 23 companies, spanning 16 indications including Breast Cancer, Osteoporosis, Vasomotor Symptoms. Explore the targeted therapies, indications, testing methods, and companies developing ER (Estrogen Receptor) drugs below.
Search ER (Estrogen Receptor) Clinical Trials
Search recruiting trials on ClinicalTrials.gov
Drugs Targeting ER (Estrogen Receptor)
| Drug | Company | Therapeutic Area |
|---|---|---|
| ACTIVELLA | Novo Nordisk | Women's Health |
| ANGELIQ | Bayer | Women's Health |
| BIJUVA | MAYNE PHARMA | Women's Health |
| CLIMARA | Bayer | Women's Health |
| CLIMARA PRO | BERLEX LABS | Women's Health |
| CONJUGATED ESTROGENS | NOVAST LABS | Oncology |
| DIVIGEL | VERTICAL PHARMS | Women's Health |
| ELESTRIN | Viatris | Women's Health |
| ESTRADIOL AND NORETHINDRONE ACETATE | BRECKENRIDGE | Women's Health |
| ESTROGEL | ASCEND THERAPS US | Women's Health |
| EVAMIST | PADAGIS US | Women's Health |
| EVISTA | Eli Lilly | Oncology |
| FASLODEX | AstraZeneca | Oncology |
| FEMRING | MILLICENT MFG PR | Women's Health |
| FULVESTRANT | HBT LABS INC | Oncology |
| FYAVOLV | Lupin | Women's Health |
| IMVEXXY | MAYNE PHARMA | Women's Health |
| MENOSTAR | Bayer | Women's Health |
| MINIVELLE | NOVEN | Women's Health |
| MYFEMBREE | SUMITOMO PHARMA AM | Women's Health |
| OSPHENA | DUCHESNAY | Women's Health |
| PREMPHASE 14/14 | Pfizer | Oncology |
| PREMPRO | Pfizer | Women's Health |
| RALOXIFENE HYDROCHLORIDE | Aurobindo Pharma | Oncology |
| SOLTAMOX | MAYNE PHARMA COMMRCL | Oncology |
| TOREMIFENE CITRATE | MSN | Oncology |
| VIVELLE-DOT | Novartis | Women's Health |
ER (Estrogen Receptor) Indications
Breast Cancer Osteoporosis Vasomotor Symptoms Vulvar and Vaginal Atrophy Hypoestrogenism Metastatic Breast Cancer Ductal Carcinoma in Situ Dyspareunia Heavy Menstrual Bleeding Uterine Leiomyoma Endometriosis Prostate Cancer Postmenopausal Osteoporosis Hypogonadism Primary Ovarian Failure Vaginal Dryness